Approved HIV reverse transcriptase inhibitors in the past decade

HIV reverse transcriptase (RT) inhibitors are the important components of highly active antiretroviral therapies (HAARTs) for anti-HIV treatment and pre-exposure prophylaxis in clinical practice. Many RT inhibitors and their combination regimens have been approved in the past ten years, but a review...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Guangdi, Wang, Yali, De Clercq, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279714/
https://www.ncbi.nlm.nih.gov/pubmed/35847492
http://dx.doi.org/10.1016/j.apsb.2021.11.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279714/
https://www.ncbi.nlm.nih.gov/pubmed/35847492
http://dx.doi.org/10.1016/j.apsb.2021.11.009

Ejemplares similares